Predictors of Improvement in Quality of Life at 12-month Follow-up in Patients Undergoing Anterior Endoscopic Skull Base Surgery
Overview
Authors
Affiliations
Background: Patients with pituitary lesions experience decrements in quality of life (QoL) and treatment aims to arrest or improve QoL decline.
Objective: To detect associations with QoL in trans-nasal endoscopic skull base surgery patients and train supervised learning classifiers to predict QoL improvement at 12 months.
Methods: A supervised learning analysis of a prospective multi-institutional dataset (451 patients) was conducted. QoL was measured using the anterior skull base surgery questionnaire (ASBS). Factors associated with QoL at baseline and at 12-month follow-up were identified using multivariate logistic regression. Multiple supervised learning models were trained to predict postoperative QoL improvement with five-fold cross-validation.
Results: ASBS at 12-month follow-up was significantly higher (132.19,SD = 24.87) than preoperative ASBS (121.87,SD = 25.72,p<0.05). High preoperative scores were significantly associated with institution, diabetes and lesions at the planum sphenoidale / tuberculum sella site. Patients with diabetes were five times less likely to report high preoperative QoL. Low preoperative QoL was significantly associated with female gender, a vision-related presentation, diabetes, secreting adenoma and the cavernous sinus site. Top quartile change in postoperative QoL at 12-month follow-up was negatively associated with baseline hypercholesterolemia, acromegaly and intraoperative CSF leak. Positive associations were detected for lesions at the sphenoid sinus site and deficient preoperative endocrine function. AdaBoost, logistic regression and neural network classifiers yielded the strongest predictive performance.
Conclusion: It was possible to predict postoperative positive change in QoL at 12-month follow-up using perioperative data. Further development and implementation of these models may facilitate improvements in informed consent, treatment decision-making and patient QoL.
Determinants of quality of life following resection of skull base tumors: a systematic review.
Sperl V, Rhomberg T, Kretschmer T Front Oncol. 2025; 14:1473261.
PMID: 39759154 PMC: 11696366. DOI: 10.3389/fonc.2024.1473261.
Artificial Intelligence, Radiomics, and Computational Modeling in Skull Base Surgery.
Suero Molina E, Ieva A Adv Exp Med Biol. 2024; 1462:265-283.
PMID: 39523271 DOI: 10.1007/978-3-031-64892-2_16.
Tumlin P, Al-Asadi Z, Turner M, Ramadan H, Makary C J Neurol Surg B Skull Base. 2024; 85(Suppl 2):e80-e85.
PMID: 39444775 PMC: 11495909. DOI: 10.1055/a-2215-6027.
Xu H, Li W, Zhang H, Wang H, Hu L, Sun X Cancer Manag Res. 2023; 15:523-535.
PMID: 37346160 PMC: 10281281. DOI: 10.2147/CMAR.S409091.
Expression and Prognostic Value of Lgr5 in Patients with Recurrent Nasopharyngeal Carcinoma.
Xu H, Li W, Song X, Zhang H, Wang H, Wang J Int J Gen Med. 2023; 16:2023-2034.
PMID: 37256083 PMC: 10226542. DOI: 10.2147/IJGM.S408991.